Latest period
$480.40M
YoY change
-24.9%
5Y CAGR
-5.4%
Peak year (2024)
$953.40M
Latest annual
$716.10M
Cash on Hand history chart for Insulet (PODD) from 2002 to 2025
Latest: $716.10M
Cash on Hand growth chart for Insulet (PODD) from 2002 to 2025
Latest: -24.9%
Cash on Hand history table for Insulet (PODD) from 2002 to 2025
| 2025 | $716.10M | -24.9% | −$237.30M | ||
| 2024 | $953.40M | +35.4% | +$249.20M | ||
| 2023 | $704.20M | +4.4% | +$29.50M | ||
| 2022 | $674.70M | -14.8% | −$116.90M | ||
| 2021 | $791.60M | -16.5% | −$156.00M | ||
| 2020 | $947.60M | +152.0% | +$571.50M | ||
| 2019 | $376.10M | +30.2% | +$87.15M | ||
| 2018 | $288.95M | -34.3% | −$151.11M | ||
| 2017 | $440.06M | +47.4% | +$141.49M | ||
| 2016 | $298.57M | +143.4% | +$175.90M | ||
| 2015 | $122.67M | -18.9% | −$28.52M | ||
| 2014 | $151.19M | +1.0% | +$1.47M | ||
| 2013 | $149.73M | +161.3% | +$92.43M | ||
| 2012 | $57.29M | -39.0% | −$36.66M | ||
| 2011 | $93.95M | -17.1% | −$19.32M | ||
| 2010 | $113.27M | -11.5% | −$14.72M | ||
| 2009 | $128.00M | +125.9% | +$71.33M | ||
| 2008 | $56.66M | -40.1% | −$37.92M | ||
| 2007 | $94.59M | +184.6% | +$61.36M | ||
| 2006 | $33.23M | +333.8% | +$25.57M | ||
| 2005 | $7.66M | -68.1% | −$16.34M | ||
| 2004 | $24.00M | +454.5% | +$19.67M | ||
| 2003 | $4.33M | -74.5% | −$12.64M | ||
| 2002 | $16.96M | — | — |
- 2025$716.10M-24.9%
- 2024$953.40M+35.4%
- 2023$704.20M+4.4%
- 2022$674.70M-14.8%
- 2021$791.60M-16.5%
- 2020$947.60M+152.0%
- 2019$376.10M+30.2%
- 2018$288.95M-34.3%
- 2017$440.06M+47.4%
- 2016$298.57M+143.4%
- 2015$122.67M-18.9%
- 2014$151.19M+1.0%
- 2013$149.73M+161.3%
- 2012$57.29M-39.0%
- 2011$93.95M-17.1%
- 2010$113.27M-11.5%
- 2009$128.00M+125.9%
- 2008$56.66M-40.1%
- 2007$94.59M+184.6%
- 2006$33.23M+333.8%
- 2005$7.66M-68.1%
- 2004$24.00M+454.5%
- 2003$4.33M-74.5%
- 2002$16.96M—
Cash on Hand values are taken from Insulet's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Insulet (PODD)
According to Insulet's latest reported financial statements, the company's latest reported cash and short-term investments is $480.40M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Insulet (PODD) cash and short-term investments totalled $716.10M – declined 24.9% year-over-year.
Through 2020–2025 (5 years), Insulet cash and short-term investments delivered a -5.4% annualised rate; with a net decline across the window.
Between 2024 and 2025, Insulet cash and short-term investments declined 24.9%, falling from $953.40M to $716.10M.
Across the available history, cash and short-term investments reached its high of $953.40M in 2024 and its low of $4.33M in 2003.
Insulet Cash on Hand by Year
Insulet Cash on Hand 2025: $716.10M
Insulet cash and short-term investments in 2025 was $716.10M, declined 24.9% below 2024.
Insulet Cash on Hand 2024: $953.40M
2024's cash and short-term investments for Insulet came in at $953.40M, surged 35.4% from 2023. This figure represents the highest annual value in the available history.
Insulet Cash on Hand 2023: $704.20M
Insulet posted cash and short-term investments of $704.20M in 2023, edged up 4.4% from 2022.
Insulet Cash on Hand 2022: $674.70M
In 2022, Insulet reported cash and short-term investments of $674.70M, declined 14.8% below 2021.
Insulet Cash on Hand 2021: $791.60M
Insulet cash and short-term investments in 2021 was $791.60M.
See more financial history for Insulet (PODD).
Sector peers by Cash on Hand
Healthcare peers of Insulet (PODD), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation